Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,035 hedge funds and large institutions have $103B invested in Allergan plc in 2015 Q2 according to their latest regulatory filings, with 126 funds opening new positions, 393 increasing their positions, 410 reducing their positions, and 169 closing their positions.
2% less capital invested
Capital invested by funds: $105B → $103B (-$1.89B)
4% less repeat investments, than reductions
Existing positions increased: 393 | Existing positions reduced: 410
4% less call options, than puts
Call options by funds: $1.15B | Put options by funds: $1.2B
3% less funds holding in top 10
Funds holding in top 10: 182 → 176 (-6)
5% less funds holding
Funds holding: 1,089 → 1,035 (-54)
25% less first-time investments, than exits
New positions opened: 126 | Existing positions closed: 169
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$564M |
| 2 |
PC
Paulson & Co
New York
|
+$457M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$341M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$208M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$191M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$901M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$875M |
| 3 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$640M |
| 4 |
VAM
Visium Asset Management
New York
|
-$435M |
| 5 |
PSCM
Pershing Square Capital Management
New York
|
-$401M |
AGN Hedge Fund Activity: Q2 2015 in Review
1,035 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q2 2015, worth a combined $103B — down 1.8% from $105B a quarter earlier.
Sellers outnumbered buyers: 169 funds closed out of AGN and 126 opened new positions — a net loss of 43 holders — while 410 trimmed existing stakes and 393 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $564M. The largest seller was Geode Capital Management, exiting entirely with an estimated $901M sold.
- 1,035 institutional investors held Allergan plc (AGN) as of Q2 2015, down from 1,089 in Q1 2015.
- Funds reported $103B of Allergan plc stock for Q2 2015, down 1.8% quarter-over-quarter.
- 126 funds opened new Allergan plc positions in Q2 2015 and 169 closed out, a net change of -43 holders.
- The largest Allergan plc buyer in Q2 2015 was T. Rowe Price Associates, an estimated $564M added.
- The largest Allergan plc seller in Q2 2015 was Geode Capital Management, an estimated $901M sold.
Based on aggregated 13F filings for Q2 2015.